Display options
Share it on

Int J Pediatr Endocrinol. 2015;2015(1):4. doi: 10.1186/1687-9856-2015-4. Epub 2015 Feb 16.

A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.

International journal of pediatric endocrinology

Anya Rothenbuhler, Agnès Linglart, Pierre Bougnères

Affiliations

  1. Department of Pediatric Endocrinology, Bicêtre Hospital, Pôle I3E, AP-HP, Paris Sud University, 94275 Le Kremlin Bicêtre, France.

PMID: 25972902 PMCID: PMC4429943 DOI: 10.1186/1687-9856-2015-4

Abstract

BACKGROUND: When given during the course of puberty, anastrozole (A), an aromatase inhibitor, has been shown to increase the predicted adult height (PAH) of GH-deficient (GHD) boys treated with recombinant human growth hormone (rhGH). Our study questioned whether this treatment could retain some of its effects in non-GHD adolescent boys if started only at the very end of puberty, a time when rhGH treatment is denied to short adolescents who have almost reached their final height.

OBJECTIVE: To explore the effect on adult height of a combination of rhGH and A, compared with rhGH alone, at the end of puberty in boys with idiopatic short stature (ISS).

METHODS: A prospective randomized study comparing rhGH + A and rhGH was conducted in 24 healthy adolescent boys aged 15.2 ± 1.2 yrs with serum testosterone at adult levels and a faltering growth velocity <3.5 cm/yr leading to a predicted adult height (PAH) <2.5 SDS. Treatments were stopped when growth velocity became <10 mm in 6 months or when height was close to 170 cm. A historical group of ISS adolescents (N = 17) matched for puberty and growth was used for comparison.

RESULTS: IGF1 levels remained within normal limits in all treated patients. Mean treatment duration was 19 months in the rhGH + A group and 11.5 months in the rhGH group (P = 6.10(-4)). Adult height reached 168.4 ± 2.6 cm in the rhGH + A group and 164.2 ± 5.6 cm in the rhGH group (P < 0.02). Adult height was 160.1 ± 2.8 cm in the historical controls.

CONCLUSION: A combination of rhGH and A, started at the very end of puberty, seems to allow boys with ISS to reach a greater adult height than rhGH alone. Larger trials are needed to confirm this preliminary observation.

Keywords: Anastrozole; End of puberty; Growth hormone; Idiopathic short stature; Short children

References

  1. Pediatr Res. 1996 Feb;39(2):295-302 - PubMed
  2. J Pediatr Endocrinol Metab. 2004 Dec;17(12):1597-606 - PubMed
  3. J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6 - PubMed
  4. Int J Pediatr Endocrinol. 2009;2009:470378 - PubMed
  5. Mol Cell Endocrinol. 2006 Jul 25;254-255:207-16 - PubMed
  6. J Pediatr. 2000 Jan;136(1):103-6 - PubMed
  7. Reprod Biol Endocrinol. 2011 Jun 21;9:93 - PubMed
  8. Horm Res. 1996;45 Suppl 2:64-6 - PubMed
  9. J Clin Endocrinol Metab. 1999 Dec;84(12):4307-16 - PubMed
  10. Clin Endocrinol (Oxf). 2006 May;64(5):510-3 - PubMed
  11. J Clin Endocrinol Metab. 2004 Mar;89(3):1066-7 - PubMed
  12. Growth Horm IGF Res. 2008 Apr;18(2):89-110 - PubMed
  13. Eur J Endocrinol. 2006 Sep;155(3):453-60 - PubMed
  14. Lancet. 2001 Jun 2;357(9270):1743-8 - PubMed
  15. Lancet. 1998 Mar 28;351(9107):940-4 - PubMed
  16. N Engl J Med. 1999 Feb 18;340(7):502-7 - PubMed
  17. J Paediatr Child Health. 2013 Mar;49(3):165-9 - PubMed
  18. Acta Paediatr. 1998 Aug;87(8):865-70 - PubMed
  19. J Bone Miner Res. 2010 Jul;25(7):1536-43 - PubMed
  20. Curr Opin Pediatr. 2010 Aug;22(4):501-7 - PubMed
  21. J Clin Endocrinol Metab. 1998 Apr;83(4):1075-9 - PubMed
  22. J Clin Endocrinol Metab. 2008 Mar;93(3):823-31 - PubMed
  23. J Anat. 2008 Feb;212(2):198-209 - PubMed
  24. Horm Res Paediatr. 2011;76 Suppl 3:52-6 - PubMed
  25. Horm Res Paediatr. 2010;74(6):428-35 - PubMed
  26. Horm Res. 1996;45 Suppl 2:59-63 - PubMed
  27. J Pediatr. 1993 Aug;123(2):215-22 - PubMed
  28. J Clin Endocrinol Metab. 2005 Sep;90(9):5188-96 - PubMed
  29. J Clin Res Pediatr Endocrinol. 2009;1(6):256-61 - PubMed
  30. J Clin Endocrinol Metab. 2011 Mar;96(3):573-9 - PubMed
  31. Pediatrics. 1994 Dec;94(6 Pt 1):832-40 - PubMed
  32. Clin Endocrinol (Oxf). 2013 Mar;78(3):405-14 - PubMed
  33. Nat Rev Endocrinol. 2011 Oct 25;8(3):135-47 - PubMed
  34. Ann Hum Biol. 1976 Mar;3(2):109-26 - PubMed
  35. J Clin Endocrinol Metab. 2005 Oct;90(10):5717-22 - PubMed
  36. Arch Pediatr. 2003 May;10(5):403-9 - PubMed
  37. J Clin Endocrinol Metab. 2008 Nov;93(11):4342-50 - PubMed
  38. Horm Res. 2009 Jan;71 Suppl 1:57-63 - PubMed
  39. Clin Endocrinol (Oxf). 2014 Jul;81(1):71-6 - PubMed
  40. Pediatrics. 2008 Apr;121(4):e975-83 - PubMed
  41. J Clin Endocrinol Metab. 2012 Feb;97(2):E213-7 - PubMed
  42. Pediatrics. 2004 Sep;114(3):744-50 - PubMed
  43. J Pediatr Endocrinol Metab. 2014 Jul;27(7-8):725-30 - PubMed
  44. Int J Pediatr Endocrinol. 2012 Jul 12;2012(1):22 - PubMed
  45. Horm Res Paediatr. 2011;76 Suppl 3:1-2 - PubMed
  46. Pediatr Endocrinol Rev. 2008 Mar;5(3):756-9 - PubMed
  47. Arch Dis Child. 1976 Mar;51(3):170-9 - PubMed
  48. J Clin Endocrinol Metab. 2004 Jul;89(7):3140-8 - PubMed
  49. J Clin Endocrinol Metab. 2001 Oct;86(10):4649-54 - PubMed
  50. Horm Res Paediatr. 2011;76 Suppl 3:40-2 - PubMed
  51. J Pediatr. 2011 Feb;158(2):187-93 - PubMed
  52. Clin Endocrinol (Oxf). 2007 Sep;67(3):407-12 - PubMed
  53. Horm Res. 2009;71(5):290-7 - PubMed
  54. J Clin Endocrinol Metab. 2005 Dec;90(12 ):6396-402 - PubMed
  55. Horm Res Paediatr. 2011;76 Suppl 3:27-9 - PubMed
  56. J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7 - PubMed
  57. J Clin Endocrinol Metab. 2006 Sep;91(9):3324-8 - PubMed
  58. Lancet. 1996 Jul 6;348(9019):13-6 - PubMed
  59. Horm Res. 1995;44(4):152-7 - PubMed
  60. Circulation. 2006 Sep 5;114(10):1056-62 - PubMed
  61. J Pediatr Endocrinol Metab. 2000 Nov-Dec;13(9):1595-602 - PubMed
  62. J Clin Endocrinol Metab. 2010 Jan;95(1):167-77 - PubMed
  63. J Clin Endocrinol Metab. 2012 Sep;97(9):3231-9 - PubMed
  64. J Pediatr. 2005 Jan;146(1):45-53 - PubMed
  65. Horm Res Paediatr. 2011;76 Suppl 3:37-9 - PubMed
  66. Int J Pediatr Endocrinol. 2014;2014(1):15 - PubMed
  67. Arch Dis Child. 1996 Sep;75(3):175-80 - PubMed
  68. J Clin Endocrinol Metab. 2012 Jan;97(1):68-72 - PubMed
  69. Horm Res Paediatr. 2011;76 Suppl 3:33-5 - PubMed
  70. J Clin Endocrinol Metab. 2010 May;95(5):2089-98 - PubMed
  71. Nat Rev Endocrinol. 2013 Jun;9(6):325-34 - PubMed
  72. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004440 - PubMed
  73. Arch Pediatr Adolesc Med. 2002 Mar;156(3):230-40 - PubMed
  74. J Pediatr. 2002 May;140(5):507-15 - PubMed
  75. Eur J Endocrinol. 2010 Apr;162(4):653-60 - PubMed
  76. J Pediatr. 1994 Aug;125(2):196-200 - PubMed
  77. Clin Endocrinol (Oxf). 2012 Jul;77(1):62-71 - PubMed
  78. J Clin Endocrinol Metab. 2002 Feb;87(2):604-11 - PubMed
  79. J Clin Endocrinol Metab. 2005 Sep;90(9):5247-53 - PubMed
  80. Pharmacoeconomics. 2004;22(8):499-524 - PubMed
  81. Horm Res Paediatr. 2010;74(6):436-7 - PubMed
  82. J Clin Endocrinol Metab. 2003 Aug;88(8):3785-93 - PubMed
  83. Horm Res Paediatr. 2011;76 Suppl 3:20-3 - PubMed
  84. Am J Phys Anthropol. 1961 Dec;19:365-72 - PubMed
  85. Horm Res Paediatr. 2011;76 Suppl 3:51-2 - PubMed
  86. Endocrinol Metab Clin North Am. 2009 Sep;38(3):613-24 - PubMed
  87. Horm Res Paediatr. 2011;76 Suppl 3:42-5 - PubMed

Publication Types